NE3107 in Adults With Long COVID

Description

Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things ("brain fog") and fatigue. Researchers will compare NE3107 to a placebo (a look-alike substance that contains no drug) to see if NE3107 works to treat neurocognitive and fatigue symptoms of long COVID. Participants will: * Take NE3107 or a placebo twice daily for 84 days * Visit the clinic 5 times for checkups and tests and have a follow up phone call

Conditions

Long COVID

Talk to us

Study Overview

On this page

Study Details

Study overview

Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things ("brain fog") and fatigue. Researchers will compare NE3107 to a placebo (a look-alike substance that contains no drug) to see if NE3107 works to treat neurocognitive and fatigue symptoms of long COVID. Participants will: * Take NE3107 or a placebo twice daily for 84 days * Visit the clinic 5 times for checkups and tests and have a follow up phone call

A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID

NE3107 in Adults With Long COVID

Condition
Long COVID
Intervention / Treatment

-

Contacts and Locations

San Francisco

Clinical Trial Site, San Francisco, California, United States, 94110

Jacksonville

Clinical Trial Site, Jacksonville, Florida, United States, 32258

Silver Spring

Clinical Trial Site, Silver Spring, Maryland, United States, 20904

Farmington Hills

Clinical Trial Site, Farmington Hills, Michigan, United States, 48334

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years to 64 years of age
  • * diagnosed with Long COVID with symptoms of fatigue and brain fog for at least 3 months
  • * agree to use birth control measures
  • * provide voluntary consent
  • * willing to allow blood collection
  • * pass all screening tests and procedures
  • * has received a COVID-19 vaccination within 30 days
  • * previous admission to the intensive care unit for COVID-19
  • * medical history of major mental or physical illness prior to COVID-19 infection

Ages Eligible for Study

18 Years to 64 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

BioVie Inc.,

Study Record Dates

2026-01